Tag: cancer diagnostics market size

Uncover key drivers, emerging technologies, and competitive movements shaping the cancer diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Cancer Diagnostics Market By The End Of 2029?

The cancer diagnostics market has demonstrated robust expansion in recent years. It is projected to increase from $23.24 billion in 2024 to $25.5 billion in 2025, maintaining a compound annual growth rate (CAGR) of 9.7%. Historically, this growth can be attributed to increasing cancer incidence, cancer screening programs, personalized medicine, and public awareness.

The cancer diagnostics market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $40.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.0%. This expansion during the projection period stems from factors such as the development of emerging markets, governmental backing, the integration of artificial intelligence (ai) and machine learning, and advancements in early detection and intervention. Key developments expected within this period encompass liquid biopsies, multi-omics methodologies, point-of-care testing, and initiatives focused on screening and early intervention.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

Which Business Drivers Are Underpinning The Growth Of The Cancer Diagnostics Market?

The significant occurrence of various cancer types acts as a primary catalyst for the cancer diagnostics market. This is attributed to the increasing incidence rates of different cancers, which compels more individuals to pursue diagnosis and treatment. Moreover, the World Health Organization (WHO) reported cancer as the second-leading cause of death globally. The National Cancer Institute (NCI) forecasts that the annual count of new cancer cases will reach 23.6 million by 2030.

What Are The Principal Segment Types In The Cancer Diagnostics Market?

The cancer diagnosticsmarket covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

Which Long-Term Trends Will Play A Crucial Role In The Cancer Diagnostics Market?

AI-powered cancer detection systems are gaining prominence as an emerging trend in the cancer diagnostics market. AI assists in enhancing the precision of image analysis within diagnostic procedures for conditions such as breast cancer and lung cancer, facilitating earlier detection. Moreover, AI contributes to reducing the occurrence of false positives in lung cancer screening, thereby improving lung cancer detection accuracy. For example, researchers at the Naval Medical Center San Diego and Google AI, Google’s AI research division, developed a robust solution featuring cancer-detecting algorithms for autonomous evaluation of lymph node biopsies. This AI solution successfully elevated the accuracy of metastatic breast cancer detection to 99%.

Which Companies Are Contributing Significantly To The Cancer Diagnostics Market Growth?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Which Region Offers The Most Opportunity For Cancer Diagnostics Market Expansion?

North America was the largest region in the cancer diagnostics market in 2024. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Browse Through More Reports Similar to the Global Cancer Diagnostics Market 2025, By The Business Research Company

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Cancer Diagnostics Market Over The Five-Year Period 2025–2029?

The dimension of the cancer diagnostics sector experienced substantial augmentation over the past few years, projecting a rise from its valuation of $23.24 billion in 2024 to an anticipated $25.5 billion in 2025, reflecting a consistent annual expansion rate, or CAGR, of 9.7%; this acceleration during the past period is directly linked to the heightened frequency of cancer cases, expanded screening initiatives, the progression of bespoke medical treatments, and greater public cognizance regarding the disease.

Anticipated for swift expansion over the immediate future, the segment dedicated to cancer diagnostics is projected to reach a valuation of $40.07 billion by 2029, achieving a compound annual growth rate (CAGR) of 12.0%; this upward trend during the projection timeframe stems from several factors, including the expansion within developing markets, supportive governmental regulations, advancements in artificial intelligence (AI) and machine learning technologies, alongside an increased focus on identifying diseases at earlier stages and initiating prompt treatments, while key developments shaping this period involve the rise of liquid biopsies, the integration of multi-omics methodologies, a shift towards point-of-care testing options, and the ongoing implementation of campaigns centered on screening and preventative early intervention measures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

What Are The Key Drivers Of Growth In The Cancer Diagnostics Market?

The widespread occurrence of numerous cancer types significantly propels the growth of the cancer diagnostics market, stemming from the fact that rising cancer diagnoses prompt more individuals to seek both detection and subsequent therapeutic interventions. Furthermore, the World Health Organization (WHO) reports that cancer stands as the second primary global cause of mortality, and projections from the National Cancer Institute (NCI) suggest that annual new cancer diagnoses are anticipated to climb to 23.6 million before the year 2030 arrives.

What Are The Segment Types Shaping The Cancer Diagnostics Market?

The cancer diagnosticsmarket covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

What Are The Major Trends Driving The Growth Of The Cancer Diagnostics Market?

Within the cancer diagnostics landscape, a notable movement is the integration of Artificial Intelligence, which serves to enhance the precision of image analysis during diagnostic procedures like those for breast and lung malignancies by identifying cancers at their nascent stages. Furthermore, the application of AI leads to fewer incorrect positive results in screenings for lung cancer, thereby boosting the overall accuracy of this detection. As an illustration, a dependable system, featuring algorithms designed for the independent assessment of lymph node biopsies, was created through a collaboration between investigators at the Naval Medical Center San Diego and Google AI; this specific AI innovation successfully elevated the precision of identifying metastatic breast cancer to an impressive ninety-nine percent.

Who Are The Primary Competitors In The Global Cancer Diagnostics Market?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

How Is Cancer Diagnostics Market Demand Varying Across Different Regions?

North America was the largest region in the cancer diagnostics market in 2024. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The Cancer Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Browse Through More Reports Similar to the Global Cancer Diagnostics Market 2025, By The Business Research Company

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Cancer Diagnostics Market, and What Factors Will Drive It?

The market size for cancer diagnostics has seen substantial growth in the past years. The forecast shows a rise from $23.24 billion in 2024 to $25.5 billion in 2025, equating to a compound annual growth rate (CAGR) of 9.7%. The growth during the historical period can be attributed to a rise in cancer cases, cancer screening initiatives, personalized healthcare, and heightened public awareness.

In the coming years, a swift expansion is foreseen for the cancer diagnostics market, with it expected to reach $40.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. Key factors driving this growth during the forecast period include a surge in emerging markets, supportive regulatory frameworks, advancements in artificial intelligence (AI) and machine learning, and a focus on early detection and intervention. The anticipated trends during this period encompass liquid biopsies, utilization of multi-omics methods, point-of-care testing, and campaigns for screening and early intervention.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

What Are the Core Growth Drivers Propelling the Cancer Diagnostics Market Forward?

The cancer diagnostics market is significantly propelled by the high incidence rate of diverse kinds of cancers. This is attributed to the rising occurrences of various cancer types, prompting more individuals to choose diagnosis and treatment. Furthermore, cancer was identified by the World Health Organization (WHO) as the second most common cause of death globally. Meanwhile, the National Cancer Institute (NCI) projects that the annual new cancer cases will escalate to 23.6 million by the year 2030.

What Segment Types Define the Cancer Diagnostics Market Structure?

The cancer diagnosticsmarket covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Cancer Diagnostics Market?

North America was the largest region in the cancer diagnostics market in 2024. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Emerging Trends that Are Influencing theCancer Diagnostics Industry Evolution?

The rise of AI-assisted cancer detection systems is a burgeoning trend in the cancer diagnostics market. AI significantly enhances the precision of image detection in diagnostic methods such as detecting breast and lung cancer, by identifying the cancers in their initial stages. AI also minimizes the occurrence of false positives in lung cancer screenings, thereby, heightening the accuracy of lung cancer detection. For example, a trustworthy solution composed of cancer-spotting algorithms for independent assessment of lymph node biopsies was built by the collective efforts of researchers at the Naval Medical Center San Diego and Google’s AI research division Google AI. This AI intervention amplified the detection precision of metastatic breast cancer to 99%.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

What Is the Definition of the Cancer Diagnostics Market?

Cancer diagnostics refers to the processes, tests, and technologies used to identify the presence of cancer in individuals. This field encompasses a range of methodologies designed to detect, stage, and characterize cancer, allowing for timely and effective treatment.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Cancer Diagnostics Market, and What Factors Will Drive It?

The market size for cancer diagnostics has seen substantial growth in the past years. The forecast shows a rise from $23.24 billion in 2024 to $25.5 billion in 2025, equating to a compound annual growth rate (CAGR) of 9.7%. The growth during the historical period can be attributed to a rise in cancer cases, cancer screening initiatives, personalized healthcare, and heightened public awareness.

In the coming years, a swift expansion is foreseen for the cancer diagnostics market, with it expected to reach $40.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. Key factors driving this growth during the forecast period include a surge in emerging markets, supportive regulatory frameworks, advancements in artificial intelligence (AI) and machine learning, and a focus on early detection and intervention. The anticipated trends during this period encompass liquid biopsies, utilization of multi-omics methods, point-of-care testing, and campaigns for screening and early intervention.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

What Are the Core Growth Drivers Propelling the Cancer Diagnostics Market Forward?

The cancer diagnostics market is significantly propelled by the high incidence rate of diverse kinds of cancers. This is attributed to the rising occurrences of various cancer types, prompting more individuals to choose diagnosis and treatment. Furthermore, cancer was identified by the World Health Organization (WHO) as the second most common cause of death globally. Meanwhile, the National Cancer Institute (NCI) projects that the annual new cancer cases will escalate to 23.6 million by the year 2030.

What Segment Types Define the Cancer Diagnostics Market Structure?

The cancer diagnosticsmarket covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Cancer Diagnostics Market?

North America was the largest region in the cancer diagnostics market in 2024. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Emerging Trends that Are Influencing theCancer Diagnostics Industry Evolution?

The rise of AI-assisted cancer detection systems is a burgeoning trend in the cancer diagnostics market. AI significantly enhances the precision of image detection in diagnostic methods such as detecting breast and lung cancer, by identifying the cancers in their initial stages. AI also minimizes the occurrence of false positives in lung cancer screenings, thereby, heightening the accuracy of lung cancer detection. For example, a trustworthy solution composed of cancer-spotting algorithms for independent assessment of lymph node biopsies was built by the collective efforts of researchers at the Naval Medical Center San Diego and Google’s AI research division Google AI. This AI intervention amplified the detection precision of metastatic breast cancer to 99%.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

What Is the Definition of the Cancer Diagnostics Market?

Cancer diagnostics refers to the processes, tests, and technologies used to identify the presence of cancer in individuals. This field encompasses a range of methodologies designed to detect, stage, and characterize cancer, allowing for timely and effective treatment.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Cancer Diagnostics Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, the cancer diagnostics market has experienced a significant growth spurt. Its size is predicted to expand from $23.24 billion in 2024, to $25.73 billion in the following year, with a compound annual growth rate (CAGR) of 10.7%. The growth observed during the historical period is due to factors such as a rise in the number of cancer cases, cancer screening initiatives, the rise of personalized medication, and increased public awareness.

How Much Will the Cancer Diagnostics Market Be Worth in 2029?

The market for cancer diagnostics is anticipated to witness a swift expansion in the forthcoming years, reaching a market value of $40.82 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.2%. The prediction for such accelerated growth during the forecast period can be credited to factors such as the expansion of emerging markets, regulatory backing, the utilization of artificial intelligence (AI) and machine learning, and early detection initiatives. The forecast period also suggests significant trends like the use of liquid biopsies, multi-omics methods, point-of-care testing, and the proliferation of screening and early intervention campaigns.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

Which is the Largest Company in the Cancer Diagnostics Market?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

What Are the Main Market Drivers in the Cancer Diagnostics Industry?

The surge in different types of cancers is one of the primary reasons propelling the cancer diagnostics market. The reason being that the escalation in instances of different kinds of cancer cases results in an increased number of individuals seeking diagnosis and treatment. Moreover, the World Health Organization (WHO) has ranked cancer as the second main reason for deaths worldwide. Estimations from the National Cancer Institute (NCI) point to an expected rise in new cancer cases per year, projecting a total of 23.6 million by 2030.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

How Is the Cancer Diagnostics Market Segments Structured?

The cancer diagnostics market covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

What Strategic Trends Are Transforming the Cancer Diagnostics Market?

AI-based systems for detecting cancer are gaining traction in the field of cancer diagnostics. Through enhancing the precision of image recognition during diagnostic procedures such as for breast and lung cancers, AI supports early-stage cancer spotting. It also decreases the occurrence of false positives during lung cancer screening, thereby enhancing the detection accuracy. For example, a trustworthy solution comprising of cancer-detecting algorithms for the independent assessment of lymph node biopsies has been invented by the Naval Medical Center San Diego and Google’s AI research arm, Google AI. This AI intervention has amplified the accuracy of metastatic breast cancer detection to 99%.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the Cancer Diagnostics Market?

North America was the largest region in the cancer diagnostics market in 2023. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

This Report Delivers Insight On:

1. How big is the cancer diagnostics market, and how is it changing globally?

2. Who are the major companies in the cancer diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the cancer diagnostics market right now?

4. Which products or customer segments are growing the most in the cancer diagnostics market?

5. What factors are helping or slowing down the growth of the cancer diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Cancer Diagnostics Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, the cancer diagnostics market has experienced a significant growth spurt. Its size is predicted to expand from $23.24 billion in 2024, to $25.73 billion in the following year, with a compound annual growth rate (CAGR) of 10.7%. The growth observed during the historical period is due to factors such as a rise in the number of cancer cases, cancer screening initiatives, the rise of personalized medication, and increased public awareness.

How Much Will the Cancer Diagnostics Market Be Worth in 2029?

The market for cancer diagnostics is anticipated to witness a swift expansion in the forthcoming years, reaching a market value of $40.82 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.2%. The prediction for such accelerated growth during the forecast period can be credited to factors such as the expansion of emerging markets, regulatory backing, the utilization of artificial intelligence (AI) and machine learning, and early detection initiatives. The forecast period also suggests significant trends like the use of liquid biopsies, multi-omics methods, point-of-care testing, and the proliferation of screening and early intervention campaigns.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

Which is the Largest Company in the Cancer Diagnostics Market?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

What Are the Main Market Drivers in the Cancer Diagnostics Industry?

The surge in different types of cancers is one of the primary reasons propelling the cancer diagnostics market. The reason being that the escalation in instances of different kinds of cancer cases results in an increased number of individuals seeking diagnosis and treatment. Moreover, the World Health Organization (WHO) has ranked cancer as the second main reason for deaths worldwide. Estimations from the National Cancer Institute (NCI) point to an expected rise in new cancer cases per year, projecting a total of 23.6 million by 2030.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

How Is the Cancer Diagnostics Market Segments Structured?

The cancer diagnostics market covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

What Strategic Trends Are Transforming the Cancer Diagnostics Market?

AI-based systems for detecting cancer are gaining traction in the field of cancer diagnostics. Through enhancing the precision of image recognition during diagnostic procedures such as for breast and lung cancers, AI supports early-stage cancer spotting. It also decreases the occurrence of false positives during lung cancer screening, thereby enhancing the detection accuracy. For example, a trustworthy solution comprising of cancer-detecting algorithms for the independent assessment of lymph node biopsies has been invented by the Naval Medical Center San Diego and Google’s AI research arm, Google AI. This AI intervention has amplified the accuracy of metastatic breast cancer detection to 99%.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the Cancer Diagnostics Market?

North America was the largest region in the cancer diagnostics market in 2023. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

This Report Delivers Insight On:

1. How big is the cancer diagnostics market, and how is it changing globally?

2. Who are the major companies in the cancer diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the cancer diagnostics market right now?

4. Which products or customer segments are growing the most in the cancer diagnostics market?

5. What factors are helping or slowing down the growth of the cancer diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the cancer diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Cancer Diagnostics Market Expected to Grow Between 2025 And 2029?

There has been a swift expansion in the size of the cancer diagnostics market recently. The market, which was worth $23.24 billion in 2024, will expand to $25.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.7%. Factors that contributed to the growth in the historic time frame include a rise in cancer occurrences, cancer screening initiatives, personalized medical treatments, and heightened public cognizance.

The market size for cancer diagnostics is anticipated to experience swift expansion in the coming few years. It is projected to reach $40.82 billion in 2029, with a compound annual growth rate (CAGR) of 12.2%. The anticipated growth in the forecast period is due to factors such as the expansion of emerging markets, regulatory backing, artificial intelligence (AI) and machine learning, coupled with early detection and intervention techniques. Dominant trends within the forecast period are expected to encompass liquid biopsies, multi-omics processes, point-of-care testing, along with screening and early intervention drives.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Cancer Diagnostics Market?

The prominence of different kinds of cancers across the globe serves as a considerable propellant for the cancer diagnostics market. This is primarily due to the escalation in cancer cases, prompting an increasing number of individuals to seek diagnosis and treatment. In line with this, the World Health Organization (WHO) has stated that cancer constitutes the world’s second most lethal disease. The National Cancer Institute (NCI), meanwhile, predicts annual new cancer cases could hit 23.6 million by 2030.

Which Key Market Segments Comprise the Cancer Diagnostics Market and Drive Its Revenue Growth?

The cancer diagnostics market covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Which Areas Are Leading Regions in the Cancer Diagnostics Market Expansion Across the Globe?

North America was the largest region in the cancer diagnostics market in 2023. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Are the Key Market Trends in the Cancer Diagnostics Market Over the Coming Years?

The use of artificial intelligence (AI) in the identification of cancer is an evolving trend seen in the cancer diagnosis market. AI enhances the precision of image identification in diagnostic procedures like breast and lung cancer checks by identifying these cancers at their early stages. Moreover, AI minimizes the occurrence of false positives during lung cancer tests thus, boosting accuracy in lung cancer detection. For instance, a dependable solution made up of cancer-detecting algorithms for the autonomous evaluation of lymph node biopsies was developed by researchers at the Naval Medical Center San Diego and Google’s AI research division, Google AI. This AI solution enhanced the precision of detecting metastatic breast cancer to 99%.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

How Is the Cancer Diagnostics Market Conceptually Defined?

Cancer diagnostics refers to the processes, tests, and technologies used to identify the presence of cancer in individuals. This field encompasses a range of methodologies designed to detect, stage, and characterize cancer, allowing for timely and effective treatment.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theCancer Diagnostics Market?

The high prevalence of various types of cancers is a key driver of the cancer diagnostics market. The rising incidence of cancer has led more people to seek diagnoses and treatment. According to the World Health Organization (WHO), cancer is the second-leading cause of death worldwide. The National Cancer Institute (NCI) has projected that the number of new cancer cases per year will reach 23.6 million by 2030.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

How Has the Cancer Diagnostics Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The cancer diagnostics market has seen rapid expansion. It will increase from $23.24 billion in 2024 to $25.73 billion in 2025, achieving a CAGR of 10.7%. Contributing factors include the rising incidence of cancer, widespread screening programs, the growth of personalized medicine, and improved public awareness.

The cancer diagnostics market is set for rapid growth, projected to reach $40.82 billion by 2029 at a CAGR of 12.2%. Key drivers include the growth of emerging markets, AI and machine learning, and increased focus on early detection. Major trends include liquid biopsies, multi-omics approaches, and the expansion of point-of-care testing technologies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theCancer Diagnostics Market?

The cancer diagnostics market is seeing a growing trend toward AI-based detection systems. AI enhances the precision of image-based cancer diagnostics, especially for breast and lung cancers, by catching them in earlier stages and reducing false positives. For example, researchers at Naval Medical Center San Diego and Google AI created an algorithm for lymph node biopsy evaluation that improved metastatic breast cancer detection accuracy to 99%.

Who Are the Key Market Players Influencing the Growth of the Corn and Cancer Diagnostics Industry?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Which Key Market Segments Comprise the Cancer Diagnostics Market and Drive Its Revenue Growth?

The cancer diagnostics market covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Which Regions Are Emerging as Leaders in the Cancer Diagnostics Market?

North America was the largest region in the cancer diagnostics market in 2023. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Reports Similar to the Global Cancer Diagnostics Market 2025, By The Business Research Company:

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/biologics-market

Metabolomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: